REACT – REAl Care for AsThma - A disease study to identify patients with severe uncontrolled asthma

Trial Identifier:	D3250R00116
Sponsor:	AstraZeneca
Start Date:	May 2024
Primary Completion Date:	November 2024
Study Completion Date:	November 2024
Condition:	Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
Germany	Berlin, Germany
Germany	Blankenhein, Germany
Germany	Bonn, Germany
Germany	Fuerstenwalde, Germany
Germany	Gauting, Germany
Germany	Weissenburg, Germany

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.